Navigation Links
New Diabetic Drugs More Effective than Older Ones

A new study suggests that patients on the newer medications for diabetics had a slightly lower risk of hospitalization//. They also spent between $920 and $1,760 less on annual total healthcare costs.

Rajesh Balkrishnan, the study’s lead author and the Merrell Dow professor of pharmacy at Ohio State University analyzed more than three years of medical records data on patients who took thiazolidinediones (TZDs) or either metformin or a sulfonylurea to control their diabetes. TZDs (pioglitazone and rosiglitazone, brand names Actos and Avandia, respectively), were approved by the Food and Drug Administration in the late 1990s. Metformin and sulfonylureas have been on the market for more than 50 years. TZD was the strongest predictor of a reduced risk of hospitalization and decreased healthcare costs in this group of patients. But TZDs can be 10 times more expensive than the older diabetes drugs.

Some of the newer drugs are more expensive but the extra expense is made up for by a reduction of cost in the healthcare aspect. The study is published in the journal Current Medical Research and Opinion. The researchers collected information on 3,191 adults enrolled in the North Carolina Medicaid program. All of the participants had Type 2 diabetes and started medications for the disease between July 2001 and December 2003.

The enrollees were divided into two groups based on the type of drug their physicians prescribed. About 1,774 took a TZD, while 1,417 took either metformin or a sulfonylurea. The researchers collected information on total healthcare expenditures and hospitalization rates for all patients. Type 2 diabetic patients are insulin resistant that is the cells in his body can’t correctly make use of the insulin and hence blood sugar levels remain high. TZDs make cells in the body more sensitive to insulin, while metformin lowers blood sugar levels and sulfonylureas boost pancreatic insulin production.

Balkrishnan said that a brand-name TZD may cost $100 a month, while a prescription for sulfonylurea or metformin may cost as little as $10 a month. Overall, the participants who took a TZD spent an average of $76 to $150 less per month on total healthcare costs. The patients who were prescribed TZDs were about 10 % less likely to be hospitalized than were the patients taking either of the other two older drugs.


'"/>




Related medicine news :

1. New Drug in Diabetic Neuropathy
2. Cinnamon May Help Diabetics
3. Eating disorder in Diabetic girls lead to eyesight damage.
4. Diabetic testing gets easier
5. Heart disease threat starts early in life for Diabetics
6. Diabetics and their babies
7. Beta-Carotene May Aid Diabetics
8. Diabetics prone to periodontitis
9. Blood Vessel Surgery Safe for Diabetics
10. Marriage does good for Diabetics
11. Niacin Safe for Diabetics
Post Your Comments:
*Name:
*Comment:
*Email:


(Date:12/2/2016)... Wilmington, Delaware (PRWEB) , ... December 02, 2016 ... ... has released a new version of its SaaS LIMS, CloudLIMS Lite. CloudLIMS Lite ... from sample entry through labeling, storing, shipping and disposal. The new version is ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... veterinarian diagnostic imaging systems and the first company to offer robotic ... a Heart at their tradeshow booth # 941 for the American Association of ...
(Date:12/2/2016)... Wexford, PA (PRWEB) , ... December 02, 2016 , ... ... manages stress and overall health, day and night. No other wearable health technology on ... management. We wanted to give poeple more meaningful insights about their health than ...
(Date:12/2/2016)... ... 02, 2016 , ... "Pro3rd Accents Volume 2 is a set of 30 ... titles with just a few clicks of the mouse," said Christina Austin - CEO ... animations. Choose from various styles with accented animations, rigid boxes, simplistic lines, and more. ...
(Date:12/2/2016)... (PRWEB) , ... December 02, 2016 , ... ... hot meals to needy individuals and families from eight different sites throughout Miami-Dade ... Thanksgiving Day. Over 1,000 volunteers worked very hard on Thanksgiving morning by putting ...
Breaking Medicine News(10 mins):
(Date:12/2/2016)... 2016 According to a ... by Product (Instruments, Reagents, Software), Technology (Immunoassay, Clinical ... Nephrology, Infectious Diseases) - Forecast to 2021" published ... USD 60.22 Billion in 2016. This market is ... during the forecast period (2016-2021) to reach USD ...
(Date:12/2/2016)...  The Addiction Treatment Advisory Group (ATAG), created ... Pharmacy (AMCP), has released detailed findings on how ... addiction crisis, including through improved access to naloxone ... newly released paper, "The Role of Managed Care ... issues around gaps and barriers to addiction treatment ...
(Date:12/2/2016)... -- Boston Scientific Corporation (NYSE: BSX ) ... assets and capabilities of the Neovasc, Inc., (NASDAQ: ... as well as a 15% equity stake in Neovasc, ... Neovasc advanced biological tissue business makes elements used in ... System. * Upon completion of the transaction, the ...
Breaking Medicine Technology: